L-ribose Production via Mannitol-1-dehydrogenase Fermentation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The high cost and limited availability of L-ribose, a crucial starting material for L-nucleoside-based pharmaceuticals, hinder the production of antiviral, antimalarial, and anticancer drugs due to expensive and inefficient synthetic routes, making these life-saving medications unaffordable for many, especially in poor countries.
Innovation Solution
A single fermentation step using ribitol as a readily available and inexpensive starting material with a NAD-dependent mannitol-1-dehydrogenase (MDH) from Apium graveolens to produce L-ribose, offering a cost-effective and efficient synthetic route that can be adapted for other rare sugars.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If L-ribose is produced from L-arabinose using xylose isomerase, then L-ribose can be obtained, but the conversion is not efficient and requires extensive and expensive purification technologies
Solution Approach 1:
The patent changes the biochemical parameters of the conversion process by using a different enzyme system (L-arabinose oxidase followed by L-sorbose reductase) instead of xylose isomerase. This enzymatic pathway achieves higher conversion efficiency and selectivity, transforming the reaction conditions to overcome the limitations of the traditional method while maintaining ease of manufacture through biochemical parameter optimization.
Solution Approach 2:
The patent replaces the mechanical/chemical purification system with a biochemical system that produces higher purity products directly. By using specific enzyme systems with high substrate specificity, the method reduces the need for extensive purification steps, effectively substituting mechanical separation processes with selective biochemical transformations.
2Ease of manufacture
If chemical process is used to convert D-mannose to L-ribose, then L-ribose can be produced, but the process requires 8 synthetic steps and does not produce high yield
Solution Approach 1:
The patent replaces the multi-step chemical synthesis mechanism with a biochemical mechanism using enzyme-catalyzed reactions. The L-arabinose oxidase and L-sorbose reductase enzymes catalyze the transformation in fewer steps with higher efficiency, substituting complex chemical synthesis pathways with selective biochemical transformations that achieve high yields with simpler process steps.
Solution Approach 2:
The patent fundamentally changes the synthetic pathway parameters by using an alternative biochemical route starting from D-mannose through L-sorbose rather than the traditional 8-step chemical synthesis from D-mannose to L-ribose. This parameter change in the reaction pathway reduces the number of steps and increases overall yield while maintaining ease of manufacture through available starting materials.
3Ease of manufacture
If three-step sequential fermentation is used to convert D-glucose to L-ribose, then L-ribose can be produced, but the cost is prohibitive
Solution Approach 1:
The patent merges multiple fermentation steps into a more efficient process by using enzymes that can be produced in a single fermentation step. The L-arabinose oxidase and L-sorbose reductase can be co-expressed or sequentially produced in one fermentation process, combining what would otherwise require separate fermentation steps into a unified manufacturing process, thereby reducing overall costs while maintaining ease of manufacture.
Solution Approach 2:
The patent replaces the multi-step fermentation mechanical process with a more efficient enzymatic system. By using purified enzymes or enzyme preparations from a single fermentation source, the method substitutes the need for multiple sequential fermentation operations, reducing process complexity and cost while maintaining the ability to produce L-ribose effectively.
4Ease of manufacture
If L-arabinose is used as starting material, then L-ribose can be produced, but L-ribose is more expensive and less readily available than L-arabinose
Solution Approach 1:
The patent inverts the traditional approach by using L-arabinose as the starting material to produce L-ribose, rather than trying to obtain L-ribose directly. Since L-arabinose is more readily available and less expensive, this inversion of the synthesis direction (starting from the cheaper, more available compound) allows production of L-ribose at lower cost while maintaining ease of manufacture through the available L-arabinose supply chain.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly reduces the production cost of L-ribose and other rare sugars, enhancing their availability and accessibility for pharmaceutical and biochemical research, thereby facilitating the development of more potent and affordable antiviral and anticancer compounds.
Implementation Method 1
A single fermentation step using ribitol as a readily available and inexpensive starting material with a NAD-dependent mannitol-1-dehydrogenase (MDH) from Apium graveolens to produce L-ribose
Implementation Method 2
A single fermentation step using ribitol as a readily available and inexpensive starting material
Data Source
AI summary
The invention provides methods and compositions for the production of L-ribitol and other rare sugars using a mannitol-1-dehydrogenase.